These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 39092928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Optimal Dosing of Meropenem in a Small Cohort of Critically Ill Children Receiving Continuous Renal Replacement Therapy.
    Tan WW, Watt KM, Boakye-Agyeman F, Cohen-Wolkowiez M, Mok YH, Yung CF, Chan YH.
    J Clin Pharmacol; 2021 Jun; 61(6):744-754. PubMed ID: 33314163
    [Abstract] [Full Text] [Related]

  • 4. Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis.
    Ehmann L, Zoller M, Minichmayr IK, Scharf C, Huisinga W, Zander J, Kloft C.
    Int J Antimicrob Agents; 2019 Sep; 54(3):309-317. PubMed ID: 31229669
    [Abstract] [Full Text] [Related]

  • 5. Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.
    Chaijamorn W, Rungkitwattanakul D, Pattharachayakul S, Singhan W, Charoensareerat T, Srisawat N.
    J Crit Care; 2020 Dec; 60():285-289. PubMed ID: 32949895
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Population Pharmacokinetics Analysis and Dosing Simulations Of Meropenem in Critically Ill Patients with Pulmonary Infection.
    Lan J, Wu Z, Wang X, Wang Y, Yao F, Zhao BX, Wang Y, Chen J, Chen C.
    J Pharm Sci; 2022 Jun; 111(6):1833-1842. PubMed ID: 35090867
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.
    An G, Creech CB, Wu N, Nation RL, Gu K, Nalbant D, Jimenez-Truque N, Fissell W, Rolsma S, Patel PC, Watanabe A, Fishbane N, Kirkpatrick CMJ, Landersdorfer CB, Winokur P.
    Antimicrob Agents Chemother; 2023 Jan 24; 67(1):e0131222. PubMed ID: 36622154
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.
    Thy M, Urien S, Bouazza N, Foissac F, Gana I, Bille E, Béranger A, Toubiana J, Berthaud R, Lesage F, Renolleau S, Tréluyer JM, Benaboud S, Oualha M.
    Clin Pharmacokinet; 2022 Nov 24; 61(11):1609-1621. PubMed ID: 36251162
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation.
    Idoate Grijalba AI, Aldaz Pastor A, Marquet P, Woillard JB.
    Eur J Clin Pharmacol; 2019 Oct 24; 75(10):1405-1414. PubMed ID: 31338539
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M, Havel E, Selke-Krulichova I, Safranek P, Bezouska J, Martinkova J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep 24; 162(3):219-226. PubMed ID: 29582860
    [Abstract] [Full Text] [Related]

  • 15. Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Meropenem in Critically Ill Patients.
    Boonpeng A, Jaruratanasirikul S, Jullangkoon M, Samaeng M, Wattanavijitkul T, Bhurayanontachai R, Pattharachayakul S.
    Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0084522. PubMed ID: 36226944
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.